MIDDLE MOLECULES AS UREMIC TOXINS - STILL A VIABLE HYPOTHESIS

被引:5
作者
VANHOLDER, R
机构
[1] Nephrology Department, University Hospital, Ghent
关键词
D O I
10.1111/j.1525-139X.1994.tb00934.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:65 / 68
页数:4
相关论文
共 38 条
[1]  
Vanholder R., Ringoir S., Adequacy of dialysis: A critical analysis. Editorial review., Kidney Int, 42, pp. 540-558, (1992)
[2]  
Scribner BH., Discussion., Trans Am Soc Artif Intern Organs, 11, pp. 29-30, (1965)
[3]  
Babb A., Farrell P., Uvelli D., Scribner B., Hemodialyzer evaluation by examination of solute molecular spectra., Trans Am Soc Artif Intern Organs, 18, pp. 98-105, (1972)
[4]  
Lowrie EG., Laird NM., Parker TF., Sargent JA., Effect of the hemodialysis prescripton on patient morbidity. Report from the National Cooperative Dialysis Study., N Engl J Med, 305, pp. 1176-1181, (1981)
[5]  
Schoots A., Mikkers F., Cramers C., De Smet R., Ringoi S., Uremic toxins and the elusive middle molecules., Nephron, 38, pp. 1-8, (1984)
[6]  
Schoots AC., Mikkers FEP., Claessens HA., De Smet R., Van Landschoot N., Ringoir S., Characterization of uremic middle molecular fractions by gas chromatography, mass spectrometry, isotachophoresis, and liquid chromatography., Clin Chem, 17, pp. 45-49, (1982)
[7]  
Furst P., Zimmerman L., Bergstrom J., Determination of endogenous middle molecules in normal and uremic body fluids., Clin Nephrol, 5, pp. 178-188, (1976)
[8]  
Lindsay RM., Henderson LW., Adequacy of dialysis, Kidney Int, 33, (1988)
[9]  
Vanholder R., Hsu C., Ringoir S., Biochemical definition of the uremic syndrome and possible therapeutic consequences, Artif Organs
[10]  
Giovannetti S., Balestri PL., Barsotti G., Methylguanidine in uremia., Arch Intern Med, 131, pp. 709-713, (1973)